PDP1 and non-small cell lung carcinoma: In addition, human NSCLC patients with PD-L1–positive scores confirmed the increased percentages of CD11c+ cells and increased PD-L1, CSF1R, and PDH expression in gated CD11c+ cells from blood (Figure 7, I–K).